TT virus (TTV)--etiologic agent of acute hepatitis?
Department of Infectious Diseases, Laboratory of Virology, Skubiszewski Medical University of Lublin.Annales Universitatis Mariae Curie-Skłodowska. Sectio D: Medicina 02/2004; 59(2):539-42.
TT virus (TTV) was first isolated in 1997 from the patient with acute posttransfusion hepatitis. This fact led to the conclusion the virus was hepatotropic and could be considered as one of causative agents of acute hepatitis. However, later it was found in other human tissues and serological studies have revealed it is widespread. Multiple tropisms of TTV and the fact the virus is found in high rate of general population, are considered arguments for lack of medical significance of TTV in human pathology. Here we present a report of two cases of acute viral hepatitis in patients hospitalized at the Department of Infectious Diseases, Medical University of Lublin, in whom TTV-DNA was found in serum and serological and virological markers of common primary and secondary hepatotropic viruses were negative. The cases of acute hepatitis we present here should be treated as a preliminary report and the comment in the discussion about the real role of TTV in human pathology.
[Show abstract] [Hide abstract]
- "Tumour development can also depend on the proviral integration site. There is growing evidence for the association of TTV with specific diseases such as post-weaning multisystemic wasting syndrome (PMWS) in swine, and rhinitis, asthma, hepatic disease, pancreatic cancer and idiopathic inflammatory myopathies in humans       . It should be emphasised that TTV has the ability to be transmitted vertically in humans and swine  . "
ABSTRACT: The safety of veterinary vaccines is of paramount importance and it is significantly jeopardised by extraneous agents such as bacteria, mycoplasma, Chlamydia and viruses. Several critical steps of vaccine manufacture involve a potential risk of viral contamination. Viruses, as extraneous, agents can be divided into two main groups. Group 1 agents, such as Pestivirus, chicken anaemia virus (CAV), and egg drop syndrome virus (EDSV) are well-known to manufacturers and authorities. Compendial detection methods, clear guidelines and legislation have been established to minimise the risk of contamination with these agents. Contrary to group 1, group 2 agents like Torque Teno virus (TTV) or RD114, a replication-competent feline gamma-retrovirus, have only recently been recognised and their role as contaminants needs further investigation. Randomly selected veterinary vaccines used between 1992 and 2009 were tested by nucleic acid amplification for CAV, EDSV, and TTV. Pestivirus contamination was examined in 33 vaccines used between 1996 and 2006 and a further 27 vaccines used between 2007 and 2009 based on random selection of these vaccines. In addition to random tests done on vaccines used from 2007 on, 12 batches of live Aujeszky's disease vaccines submitted to our laboratory for Official Control Authority Batch Release (OCABR) were also tested for Pestivirus.Biologicals 03/2010; 38(3):346-9. DOI:10.1016/j.biologicals.2010.01.007 · 1.21 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.